Mequinol; Tretinoin Patent Expiration
Mequinol; Tretinoin is Used for treating hyperpigmentary disorders. It was first introduced by Almirall Llc
Mequinol; Tretinoin Patents
Given below is the list of patents protecting Mequinol; Tretinoin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Solage | US6353029 | Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
Aug 24, 2020
(Expired) | Almirall |
| Solage | US5194247 | Synergistic skin depigmentation composition |
Dec 10, 2013
(Expired) | Almirall |
Mequinol; Tretinoin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List